{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:18:34Z","timestamp":1778635114048,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["cidjournal.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.clindermatol.2014.07.009","type":"journal-article","created":{"date-parts":[[2014,11,26]],"date-time":"2014-11-26T06:17:01Z","timestamp":1416982621000},"page":"19-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Protecting people against leprosy: Chemoprophylaxis and immunoprophylaxis"],"prefix":"10.1016","volume":"33","author":[{"given":"Jan Hendrik","family":"Richardus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Oskam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2014.07.009_bb0005","series-title":"Enhanced Global Strategy for Further Reducing the Disease Burden Due to Leprosy (Plan Period: 2011\u20132015)","author":"World Health Organization","year":"2009"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0010","first-page":"317","article-title":"Global leprosy situation","volume":"87","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0015","doi-asserted-by":"crossref","first-page":"330","DOI":"10.47276\/lr.78.4.330","article-title":"The impact of leprosy control on the transmission of M. leprae: is elimination being attained?","volume":"78","author":"Richardus","year":"2007","journal-title":"Lepr Rev"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0020","first-page":"249","article-title":"Close contacts with leprosy in newly diagnosed leprosy patients in a high and low endemic area: comparison between Bangladesh and Thailand","volume":"73","author":"Richardus","year":"2005","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0025","first-page":"98","article-title":"Four years\u2019 experience with dapsone as prophylaxis against leprosy","volume":"42","author":"Otsyula","year":"1971","journal-title":"Lepr Rev"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0030","first-page":"155","article-title":"DDS prophylaxis against leprosy","volume":"39","author":"Wardekar","year":"1967","journal-title":"Lepr India"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0035","first-page":"247","article-title":"Chemoprophylaxis in leprosy","volume":"41","author":"Noordeen","year":"1969","journal-title":"Lepr India"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0040","first-page":"635","article-title":"Chemoprophylaxis among contacts of non-lepromatous leprosy","volume":"48","author":"Noordeen","year":"1976","journal-title":"Lepr India"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0045","first-page":"504","article-title":"Long term effects of chemoprophylaxis among contacts of lepromatous cases. Results of 8 1\u20442 years follow-up","volume":"49","author":"Noordeen","year":"1976","journal-title":"Lepr India"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0050","first-page":"515","article-title":"Extended studies on chemoprophylaxis against leprosy","volume":"67","author":"Noordeen","year":"1978","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0055","first-page":"307","article-title":"Chemoprophylaxis against leprosy with acedapsone","volume":"78","author":"Neelan","year":"1983","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0060","first-page":"251","article-title":"Limited duration acedapsone prophylaxis in leprosy","volume":"58","author":"Neelan","year":"1986","journal-title":"Indian J Lepr"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0065","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1590\/S1020-49892009001000009","article-title":"Chemoprophylaxis in contacts of patients with leprosy: systematic review and meta-analysis","volume":"26","author":"Reveiz","year":"2009","journal-title":"Pan Am J Public Health"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0070","first-page":"810","article-title":"Implementation of chemoprophylaxis of leprosy in the Southern Marquesas with a single dose of 25 mg per kg rifampin","volume":"57","author":"Cartel","year":"1989","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0075","first-page":"416","article-title":"Chemoprophylaxis of leprosy with a single dose of 25 mg per kg rifampin in the southern Marquesas; results after four years","volume":"60","author":"Cartel","year":"1992","journal-title":"Int J Lepr Other Mycobact Dis"},{"issue":"71 Suppl.","key":"10.1016\/j.clindermatol.2014.07.009_bb0080","first-page":"S33","article-title":"Chemoprophylaxis of leprosy in the southern Marquesas with a single 25 mg\/kg dose of rifampicin. Results after 10 years","volume":"71","author":"Nguyen","year":"2000","journal-title":"Lepr Rev"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0085","first-page":"S30","article-title":"Summary of leprosy chemoprophylaxis programs in the Western Pacific Region","volume":"67","author":"Blanc","year":"1999","journal-title":"Int J Lepr Other Mycobact Dis"},{"issue":"71 Suppl.","key":"10.1016\/j.clindermatol.2014.07.009_bb0090","first-page":"S21","article-title":"Leprosy chemoprophylaxis in Micronesia","author":"Diletto","year":"2000","journal-title":"Lepr Rev"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0095","series-title":"Epidemiological Review of Leprosy in the Western Pacific Region, 2008\u20132010","author":"World Health Organization","year":"2011"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0100","first-page":"S1","article-title":"Proceedings of the Workshop on the Prevention of Leprosy. Pohnpei, Federated States of Micronesia","volume":"67","year":"1999","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0105","first-page":"S38","article-title":"Preventive treatment of leprosy: needs, opportunities, and feasibility","volume":"67","author":"Smith","year":"1999","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0110","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4269\/ajtmh.2005.72.443","article-title":"Prevention of leprosy using rifampicin as chemoprophylaxis","volume":"72","author":"Bakker","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0115","doi-asserted-by":"crossref","first-page":"376","DOI":"10.47276\/lr.75.4.376","article-title":"A study on transmission and a trial of chemoprophylaxis in contacts of leprosy patients: design, methodology and recruitment findings of COLEP","volume":"75","author":"Moet","year":"2004","journal-title":"Lepr Rev"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0120","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/bmj.39500.885752.BE","article-title":"Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial","volume":"336","author":"Moet","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0125","doi-asserted-by":"crossref","first-page":"292","DOI":"10.47276\/lr.83.3.292","article-title":"Patient-related factors predicting the effectiveness of rifampicin chemoprophylaxis in contacts: 6 year follow up of the COLEP cohort in Bangladesh","volume":"83","author":"Feenstra","year":"2012","journal-title":"Lepr Rev"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0130","doi-asserted-by":"crossref","first-page":"7125","DOI":"10.1016\/j.vaccine.2009.09.054","article-title":"Protective effect of the combination BCG vaccination and rifampicin prophylaxis in leprosy prevention","volume":"27","author":"Schuring","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0135","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/0140-6736(92)91056-E","article-title":"Immunoprophylactic trial with combined Mycobacterium leprae\/BCG vaccine against leprosy: preliminary results","volume":"339","author":"Convit","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0140-6736(96)02166-6","article-title":"Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group","volume":"348","author":"Karonga Prevention Trial Group","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0145","first-page":"369","article-title":"Comparative leprosy vaccine trial in south India","volume":"70","author":"Gupte","year":"1998","journal-title":"Indian J Lepr"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0150","first-page":"540","article-title":"Antileprosy potentials of ICRC vaccine. A study in patients and healthy volunteers","volume":"51","author":"Deo","year":"1983","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0155","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0264-410X(90)90134-8","article-title":"Immunotherapeutic effects of a vaccine based on a saprophytic cultivable mycobacterium, Mycobacterium w in multibacillary leprosy patients","volume":"8","author":"Talwar","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0160","doi-asserted-by":"crossref","first-page":"127","DOI":"10.47276\/lr.76.2.127","article-title":"Immunoprophylactic effects of the anti-leprosy Mw vaccine in household contacts of leprosy patients: clinical field trials with a follow up of 8-10 years","volume":"76","author":"Sharma","year":"2005","journal-title":"Lepr Rev"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0165","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1016\/S0264-410X(01)00052-4","article-title":"Vaccination against leprosy at Ben San Leprosy Centre, Ho Chi Minh City, Vietnam","volume":"19","author":"Truoc","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0170","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1473-3099(06)70412-1","article-title":"The role of BCG in prevention of leprosy: a meta-analysis","volume":"6","author":"Setia","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0175","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/0378-6323.31891","article-title":"Protective effect of bacillus Calmette Guerin (BCG) vaccine in the prevention of leprosy: a meta-analysis","volume":"73","author":"Zodpey","year":"2007","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0180","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1586\/erv.09.161","article-title":"BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control","volume":"9","author":"Merle","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0185","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.trstmh.2008.04.015","article-title":"Effectiveness of BCG vaccination among leprosy contacts: a cohort study","volume":"102","author":"Duppre","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0190","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.4161\/hv.7.11.16848","article-title":"Advances and hurdles on the way toward a leprosy vaccine","volume":"7","author":"Duthie","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0195","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/35059006","article-title":"Massive gene decay in the leprosy bacillus","volume":"409","author":"Cole","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0200","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1128\/CVI.00432-07","article-title":"Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection","volume":"15","author":"Geluk","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0205","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2334-11-26","article-title":"Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development","volume":"11","author":"Sampaio","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0210","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.4049\/jimmunol.1103452","article-title":"New biomarkers with relevance to leprosy diagnosis applicable in areas hyperendemic for leprosy","volume":"188","author":"Geluk","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0215","doi-asserted-by":"crossref","first-page":"353","DOI":"10.47276\/lr.80.4.353","article-title":"Enhanced global strategy for further reducing the disease burden due to leprosy: 2011-2015","volume":"80","author":"Pannikar","year":"2009","journal-title":"Lepr Rev"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0220","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0140-6736(08)60433-X","article-title":"Leprosy strategy is about control, not eradication","volume":"371","author":"Smith","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0225","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1473-3099(11)70006-8","article-title":"Leprosy now: epidemiology, progress, challenges, and research gaps","volume":"11","author":"Rodrigues","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0230","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1086\/499278","article-title":"Physical distance, genetic relationship, age, and leprosy classification are independent risk factors for leprosy in contacts of patients with leprosy","volume":"193","author":"Moet","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0235","doi-asserted-by":"crossref","first-page":"e198","DOI":"10.1371\/journal.pntd.0000198","article-title":"The prevalence of previously undiagnosed leprosy in the general population of northwest Bangladesh","volume":"2","author":"Moet","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0240","doi-asserted-by":"crossref","first-page":"e1330","DOI":"10.1371\/journal.pntd.0001330","article-title":"The long-term effect of current and new interventions on the new case detection of leprosy: a modeling study","volume":"5","author":"Fischer","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0245","series-title":"Brussels, Belgium: 18th International Leprosy Congress","article-title":"The combined effect of chemoprophylaxis with rifampicin and immunoprophylaxis with BCG, in the prevention of leprosy in contacts: a randomized controlled trial","author":"Alam","year":"2013"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0250","first-page":"196","article-title":"Serology: recent developments, strengths, limitations and prospects: a state of the art overview","volume":"74","author":"Oskam","year":"2003","journal-title":"Lepr Rev"},{"issue":"Suppl. 2","key":"10.1016\/j.clindermatol.2014.07.009_bb0255","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1590\/S0037-86822008000700004","article-title":"Leprosy serology using PGL-I: a systematic review","volume":"41","author":"Moura","year":"2008","journal-title":"Rev Soc Bras Med Trop"},{"issue":"Suppl. 1","key":"10.1016\/j.clindermatol.2014.07.009_bb0260","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1590\/S0074-02762012000900014","article-title":"Identification of serological biomarkers of infection, disease progression and treatment efficacy for leprosy","volume":"107","author":"Spencer","year":"2012","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0265","doi-asserted-by":"crossref","first-page":"80","DOI":"10.47276\/lr.82.1.80","article-title":"Report on the sixth meeting of the IDEAL (Initiative for Diagnostic and Epidemiological Assays for Leprosy) consortium held in Beijing, China on 23-25 August 2010","volume":"82","author":"Dockrell","year":"2011","journal-title":"Lepr Rev"},{"key":"10.1016\/j.clindermatol.2014.07.009_bb0270","first-page":"1","article-title":"Biomarkers for leprosy: would you prefer T (cells)?","volume":"84","author":"Geluk","year":"2013","journal-title":"Lepr Rev"},{"issue":"Suppl. 1","key":"10.1016\/j.clindermatol.2014.07.009_bb0275","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1590\/S0074-02762012000900027","article-title":"The potential for vaccination in leprosy elimination: new tools for targeted interventions","volume":"107","author":"Duthie","year":"2012","journal-title":"Mem Inst Oswaldo Cruz"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X14001515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X14001515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T08:55:19Z","timestamp":1650704119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X14001515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0738081X14001515"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2014.07.009","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protecting people against leprosy: Chemoprophylaxis and immunoprophylaxis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2014.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}